CBE ID
2550e
Project
Endorsed
Endorsement and Maintenance (E&M) Cycle
Is Under Review
No
Measure Description
Percentage of patients aged 18 and older with a diagnosis of gout and either tophus/tophi or at least two gout flares (attacks) in the past year who have a serum urate level > 6.0 mg/dL, who are prescribed urate lowering therapy (ULT)
- Measure TypeElectronic Clinical Quality Measure (eCQM)Level Of AnalysisCare SettingNumerator
Patients who are prescribed urate lowering therapy (ULT)
DenominatorAdult patients aged 18 and older with a diagnosis of gout and a serum urate level > 6.8 mg/dL who have at least one of the following: presence of tophus/tophi or two or more gout flares (attacks) in the past year
ExclusionsNone
Testing Data Sources
- Measure StructureClinical Condition Topic AreaNational Quality Strategy PrioritiesEffective Communication and Care CoordinationQuality of Life/Functional Status
- Risk Adjustment
- Current or planned use(s)
- Most Recent Endorsement ActivityApproval for Trial Use Removed Primary Care and Chronic Illness Spring Cycle 2019Initial EndorsementEndorsement StatusLast UpdatedRemoval Date
- StewardSteward Organization EmailSteward Organization Copyright
N/A - measure is still being tested